Henry Gosebruch appointed as Chief Executive Officer of Galapagos
MECHELEN: Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company focused on advancing cell therapies and transformative medicine, announced a strategic update Tuesday, including a re-evaluation of its previously planned corporate separation, a leadership transition, and changes to its…